BCG (Bacillus Calmette-Guerin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BCG (Bacillus Calmette-Guerin), covering 2019-09-23 to 2019-09-23. Get the full timeline:
Most recent: Clinical Trial Update: Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma [Phase 2]